PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Daunorubicin (Cerubidine)

Subscribe to Selected New Research on Daunorubicin

1771 relevant articles (155 outcomes, 249 trials/studies) found for this Drug

Description: A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.

Also Known As:

Cerubidine; Dauno-Rubidomycine; Daunoblastin; Daunoblastine; Daunorubicin Hydrochloride; NSC-82151; Dauno Rubidomycine; Hydrochloride, Daunorubicin; NSC 82151; NSC82151; Daunomycin; Rubidomycin; Rubomycin; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-

Relationship Network

Drug Context: Research Results

-

Organic Chemicals: 42

-

Hydrocarbons: 362

-

Cyclic Hydrocarbons: 3

-

Aromatic Hydrocarbons: 121

-

Aromatic Polycyclic Hydrocarbons: 617

-

-

Anthracyclines: 1388

-

Daunorubicin: 1771

*

Doxorubicin: 15671

*

Idarubicin: 598

*

*

*

LSA2-L2 protocol: 30

*

PVDA protocol: 24

*

daunorubicinol: 20

*

idarubicinol: 19

*

detorubicin: 13

*

Nogalamycin: 13

*

*

DCMP protocol: 9

*

daunorubicin-DNA: 8

*

*

4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulfonyldaunorubicin: 6

*

5-iminodaunorubicin: 5

*

DAT protocol 1: 5

*

RATE protocol: 5

*

3'-(4-morpholinyl)-3'-deaminodaunorubicin: 4

*

7-O-(2,6-dideoxy-2-fluorotalopyranosyl)daunomycinone: 4

*

*

N,N-dimethyldaunorubicin: 3

*

ALL-BFM-95 protocol: 2

*

*

N,N-dibenzyldaunorubicin: 2

*

N-(4-(daunorubicin-N-carbonyl-oxymethyl)phenyl)-O-glucuronyl carbamate: 2

*

3'-(4-methoxy-1-piperidinyl)-3'-deaminodaunorubicin: 1

*

3'-epidaunorubicin: 1

*

AIEOP acute lymphoblastic leukemia protocol: 1

*

AML8A protocol: 1

*

AML92 protocol: 1

*

BH-AC-DMP protocol: 1

*

cyanomorpholinodaunomycin: 1

*

DATV regimen: 1

*

daunomycin-arachidonic acid complex: 1

*

daunomycin-dextran: 1

*

daunorubicin polyaspartic acid: 1

*

*

DBVCy protocol: 1

*

DC(M)VP protocol: 1

*

DON protocol: 1

*

*

L-6 protocol: 1

*

*

MRC AML 10 protocol: 1

*

N-(p-azidobenzoyl)daunorubicin: 1

*

N-acetyldaunomycin: 1

*

N-aconityldaunomycin: 1

*

N-ethyl-13-dihydrorubomycin: 1

*

New York protocol: 1

*

*

06-Paris-LA-66 protocol

*

1-hydroxy-13-dihydrodaunomycin

*

11-deoxydaunomycin

*

11mer daunomycin-conjugated GT

*

13-methyl-13-dihydrodaunorubicin

*

14-bromodaunorubicin

*

14-chlorodaunorubicin

*

14-quinaldinoyloxydaunorubicin

*

14-salicyloyldaunorubicin

*

2'-C-methyldaunomycin

*

2-fluoro-4-demethoxydaunomycin

*

3',6'-dihydroxy-3',5'-diepidaunorubicin

*

3'-azidodaunorubicin

*

3'-C-methyldaunorubicin

*

3'-deamino-3'-hydroxydaunorubicin

*

3'-desamino-3'-dimethylformamidine rubomycin

*

3'-hydroxy-3',5'-diepidaunorubicin

*

3-fluoro-4-demethoxydaunomycin

*

4 O-daunosaminyl-2,4,5,12-tetrahydroxy-2-nonanoyl-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

4'-deoxydaunomycin

*

4'-epidaunomycin

*

4(O)-daunosaminyl-2,4,5,12-tetrahydroxy-2-pentanoyl-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

4-demethoxy-3'-deamino-4'-deoxy-4'-aminodaunorubicin

*

4-methoxydaunorubicin

*

4-O-daunosaminyl-2,4,5,12-tetrahydroxy-2-(2-methylpropanoyl)-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

5-aminodaunorubicin

*

5-imino-N-(1-carboethoxypropen-1-yl)daunorubicin

*

7(O)-(2,3,5-trideoxy-3-C-formylpentafuranosyl)daunomycinone

*

*

7-deoxy-13-dihydrodaunomycinone

*

7-deoxydaunomycinone

*

7-O-(2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)talopyranosyl)daunomycinone

*

7-O-(2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)talopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-2-fluorotalopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-6,6,6-trifluoro-lyxo-hexopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-alpha-ribo-hexopyranosyl)daunomycinone

*

7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-lyxo-hexopyranosyl)daunomycinone

*

7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-arabino-hexopyranosyl)daunomycinone

*

7-O-(6-deoxy-2-O-methyltalopyranosyl)daunomycinone

*

7-O-ribofuranosyldaunomycinone

*

9,10-anhydrodaunorubicin

*

9-dehydroxydaunomycin

*

*

*

AIEOP 8703 protocol

*

AIEOP protocol 8202

*

*

alanylleucyl-daunorubicin

*

ALHR88 protocol

-

Polycyclic Compounds: 59

-

Aromatic Polycyclic Hydrocarbons: 617

-

-

Anthracyclines: 1388

-

Daunorubicin: 1771

*

Doxorubicin: 15671

*

Idarubicin: 598

*

*

*

LSA2-L2 protocol: 30

*

PVDA protocol: 24

*

daunorubicinol: 20

*

idarubicinol: 19

*

detorubicin: 13

*

Nogalamycin: 13

*

*

DCMP protocol: 9

*

daunorubicin-DNA: 8

*

*

4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulfonyldaunorubicin: 6

*

5-iminodaunorubicin: 5

*

DAT protocol 1: 5

*

RATE protocol: 5

*

3'-(4-morpholinyl)-3'-deaminodaunorubicin: 4

*

7-O-(2,6-dideoxy-2-fluorotalopyranosyl)daunomycinone: 4

*

*

N,N-dimethyldaunorubicin: 3

*

ALL-BFM-95 protocol: 2

*

*

N,N-dibenzyldaunorubicin: 2

*

N-(4-(daunorubicin-N-carbonyl-oxymethyl)phenyl)-O-glucuronyl carbamate: 2

*

3'-(4-methoxy-1-piperidinyl)-3'-deaminodaunorubicin: 1

*

3'-epidaunorubicin: 1

*

AIEOP acute lymphoblastic leukemia protocol: 1

*

AML8A protocol: 1

*

AML92 protocol: 1

*

BH-AC-DMP protocol: 1

*

cyanomorpholinodaunomycin: 1

*

DATV regimen: 1

*

daunomycin-arachidonic acid complex: 1

*

daunomycin-dextran: 1

*

daunorubicin polyaspartic acid: 1

*

*

DBVCy protocol: 1

*

DC(M)VP protocol: 1

*

DON protocol: 1

*

*

L-6 protocol: 1

*

*

MRC AML 10 protocol: 1

*

N-(p-azidobenzoyl)daunorubicin: 1

*

N-acetyldaunomycin: 1

*

N-aconityldaunomycin: 1

*

N-ethyl-13-dihydrorubomycin: 1

*

New York protocol: 1

*

*

06-Paris-LA-66 protocol

*

1-hydroxy-13-dihydrodaunomycin

*

11-deoxydaunomycin

*

11mer daunomycin-conjugated GT

*

13-methyl-13-dihydrodaunorubicin

*

14-bromodaunorubicin

*

14-chlorodaunorubicin

*

14-quinaldinoyloxydaunorubicin

*

14-salicyloyldaunorubicin

*

2'-C-methyldaunomycin

*

2-fluoro-4-demethoxydaunomycin

*

3',6'-dihydroxy-3',5'-diepidaunorubicin

*

3'-azidodaunorubicin

*

3'-C-methyldaunorubicin

*

3'-deamino-3'-hydroxydaunorubicin

*

3'-desamino-3'-dimethylformamidine rubomycin

*

3'-hydroxy-3',5'-diepidaunorubicin

*

3-fluoro-4-demethoxydaunomycin

*

4 O-daunosaminyl-2,4,5,12-tetrahydroxy-2-nonanoyl-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

4'-deoxydaunomycin

*

4'-epidaunomycin

*

4(O)-daunosaminyl-2,4,5,12-tetrahydroxy-2-pentanoyl-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

4-demethoxy-3'-deamino-4'-deoxy-4'-aminodaunorubicin

*

4-methoxydaunorubicin

*

4-O-daunosaminyl-2,4,5,12-tetrahydroxy-2-(2-methylpropanoyl)-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

5-aminodaunorubicin

*

5-imino-N-(1-carboethoxypropen-1-yl)daunorubicin

*

7(O)-(2,3,5-trideoxy-3-C-formylpentafuranosyl)daunomycinone

*

*

7-deoxy-13-dihydrodaunomycinone

*

7-deoxydaunomycinone

*

7-O-(2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)talopyranosyl)daunomycinone

*

7-O-(2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)talopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-2-fluorotalopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-6,6,6-trifluoro-lyxo-hexopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-alpha-ribo-hexopyranosyl)daunomycinone

*

7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-lyxo-hexopyranosyl)daunomycinone

*

7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-arabino-hexopyranosyl)daunomycinone

*

7-O-(6-deoxy-2-O-methyltalopyranosyl)daunomycinone

*

7-O-ribofuranosyldaunomycinone

*

9,10-anhydrodaunorubicin

*

9-dehydroxydaunomycin

*

*

*

AIEOP 8703 protocol

*

AIEOP protocol 8202

*

*

alanylleucyl-daunorubicin

*

ALHR88 protocol

-

Carbohydrates: 2945

-

Glycosides: 357

-

Aminoglycosides: 1129

-

Anthracyclines: 1388

-

Daunorubicin: 1771

*

Doxorubicin: 15671

*

Idarubicin: 598

*

*

*

LSA2-L2 protocol: 30

*

PVDA protocol: 24

*

daunorubicinol: 20

*

idarubicinol: 19

*

detorubicin: 13

*

Nogalamycin: 13

*

*

DCMP protocol: 9

*

daunorubicin-DNA: 8

*

*

4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulfonyldaunorubicin: 6

*

5-iminodaunorubicin: 5

*

DAT protocol 1: 5

*

RATE protocol: 5

*

3'-(4-morpholinyl)-3'-deaminodaunorubicin: 4

*

7-O-(2,6-dideoxy-2-fluorotalopyranosyl)daunomycinone: 4

*

*

N,N-dimethyldaunorubicin: 3

*

ALL-BFM-95 protocol: 2

*

*

N,N-dibenzyldaunorubicin: 2

*

N-(4-(daunorubicin-N-carbonyl-oxymethyl)phenyl)-O-glucuronyl carbamate: 2

*

3'-(4-methoxy-1-piperidinyl)-3'-deaminodaunorubicin: 1

*

3'-epidaunorubicin: 1

*

AIEOP acute lymphoblastic leukemia protocol: 1

*

AML8A protocol: 1

*

AML92 protocol: 1

*

BH-AC-DMP protocol: 1

*

cyanomorpholinodaunomycin: 1

*

DATV regimen: 1

*

daunomycin-arachidonic acid complex: 1

*

daunomycin-dextran: 1

*

daunorubicin polyaspartic acid: 1

*

*

DBVCy protocol: 1

*

DC(M)VP protocol: 1

*

DON protocol: 1

*

*

L-6 protocol: 1

*

*

MRC AML 10 protocol: 1

*

N-(p-azidobenzoyl)daunorubicin: 1

*

N-acetyldaunomycin: 1

*

N-aconityldaunomycin: 1

*

N-ethyl-13-dihydrorubomycin: 1

*

New York protocol: 1

*

*

06-Paris-LA-66 protocol

*

1-hydroxy-13-dihydrodaunomycin

*

11-deoxydaunomycin

*

11mer daunomycin-conjugated GT

*

13-methyl-13-dihydrodaunorubicin

*

14-bromodaunorubicin

*

14-chlorodaunorubicin

*

14-quinaldinoyloxydaunorubicin

*

14-salicyloyldaunorubicin

*

2'-C-methyldaunomycin

*

2-fluoro-4-demethoxydaunomycin

*

3',6'-dihydroxy-3',5'-diepidaunorubicin

*

3'-azidodaunorubicin

*

3'-C-methyldaunorubicin

*

3'-deamino-3'-hydroxydaunorubicin

*

3'-desamino-3'-dimethylformamidine rubomycin

*

3'-hydroxy-3',5'-diepidaunorubicin

*

3-fluoro-4-demethoxydaunomycin

*

4 O-daunosaminyl-2,4,5,12-tetrahydroxy-2-nonanoyl-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

4'-deoxydaunomycin

*

4'-epidaunomycin

*

4(O)-daunosaminyl-2,4,5,12-tetrahydroxy-2-pentanoyl-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

4-demethoxy-3'-deamino-4'-deoxy-4'-aminodaunorubicin

*

4-methoxydaunorubicin

*

4-O-daunosaminyl-2,4,5,12-tetrahydroxy-2-(2-methylpropanoyl)-1,2,3,4-tetrahydro-6,11-naphthacenedione

*

5-aminodaunorubicin

*

5-imino-N-(1-carboethoxypropen-1-yl)daunorubicin

*

7(O)-(2,3,5-trideoxy-3-C-formylpentafuranosyl)daunomycinone

*

*

7-deoxy-13-dihydrodaunomycinone

*

7-deoxydaunomycinone

*

7-O-(2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)talopyranosyl)daunomycinone

*

7-O-(2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)talopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-2-fluorotalopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-6,6,6-trifluoro-lyxo-hexopyranosyl)daunomycinone

*

7-O-(3-amino-2,3,6-trideoxy-alpha-ribo-hexopyranosyl)daunomycinone

*

7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-lyxo-hexopyranosyl)daunomycinone

*

7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-arabino-hexopyranosyl)daunomycinone

*

7-O-(6-deoxy-2-O-methyltalopyranosyl)daunomycinone

*

7-O-ribofuranosyldaunomycinone

*

9,10-anhydrodaunorubicin

*

9-dehydroxydaunomycin

*

*

*

AIEOP 8703 protocol

*

AIEOP protocol 8202

*

*

alanylleucyl-daunorubicin

*

ALHR88 protocol